First Light Asset Management’s Harvard Bioscience HBIO Stock Holding History

First Light Asset Management’s Portfolio HBIO Stock Details HBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-58,815	Closed	-$1.18M	–	75
2019 Q2	$1.18M	Sell	58,815 -648,209	-92%	-$19M	0.16%	55
2019 Q1	$30.5M	Buy	707,024 +6,065	+0.9%	+$220K	3.96%	7
2018 Q4	$22.3M	Buy	700,959 +73,947	+12%	+$2.91M	3.55%	11
2018 Q3	$32.9M	Buy	627,012 +31,911	+5%	+$1.79M	5.31%	6
2018 Q2	$31.8M	Buy	595,101 +50,972	+9%	+$2.61M	4.96%	8
2018 Q1	$27.2M	Buy	544,129 +80,264	+17%	+$3.6M	5.97%	4
2017 Q4	$15.3M	Buy	463,865 +52,237	+13%	+$1.76M	4.2%	8
2017 Q3	$15.4M	Buy	411,628 +54,408	+15%	+$1.61M	4.89%	5
2017 Q2	$9.11M	Buy	357,220 +36,771	+11%	+$910K	3.06%	8
2017 Q1	$8.33M	Buy	320,449 +46,036	+17%	+$1.33M	3.18%	9
2016 Q4	$8.37M	Sell	274,413 -8,138	-3%	-$207K	3.68%	8
2016 Q3	$7.68M	Buy	282,551 +8,531	+3%	+$237K	3.31%	8
2016 Q2	$7.84M	Buy	274,020 +59,001	+27%	+$1.88M	3.63%	6
2016 Q1	$6.49M	Buy	215,019 +11,044	+5%	+$313K	3.28%	7
2015 Q4	$7.08M	Buy	203,975 +5,756	+3%	+$197K	2.96%	7
2015 Q3	$7.49M	Buy	198,219 +27,417	+16%	+$1.28M	3.7%	6
2015 Q2	$9.74M	Buy	170,802 +14,552	+9%	+$828K	4.58%	5
2015 Q1	$9.09M	Buy	156,250 +14,978	+11%	+$805K	4.64%	4
2014 Q4	$8.01M	Buy	141,272 +34,888	+33%	+$1.66M	4.54%	5
2014 Q3	$4.35M	Buy	106,384 +4,955	+5%	+$228K	2.98%	9
2014 Q2	$4.62M	Buy	101,429 +5,279	+5%	+$222K	3.11%	10
2014 Q1	$4.56M	Buy	+96,150	New	+$4.38M	3.23%	8

Other funds holding HBIO

ECM

Engine Capital Management New York $828M AUM 6.49% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

GIM

Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

DGHMC

Dalton, Greiner, Hartman, Maher & Co New York $126M AUM 92.88% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

KCM

Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Heartland Advisors Milwaukee, Wisconsin $1.96B AUM 28.26% 1-Year Est. Return

First Light Asset Management's HBIO Position: Q3 2019 in Review

First Light Asset Management sold out of Harvard Bioscience (HBIO) in Q3 2019, closing a stake of 58,815 shares — an estimated $1.18M sold.

First Light Asset Management first reported a position in HBIO in Q1 2014 and held it in 22 quarters. The position peaked at $32.9M in Q3 2018. 71 funds tracked by Wall St. Rank hold HBIO as of Q3 2019.

First Light Asset Management reported no remaining Harvard Bioscience position as of Q3 2019 after selling out during the quarter.
First Light Asset Management sold 58,815 Harvard Bioscience shares in Q3 2019, an estimated $1.18M.
First Light Asset Management first reported a position in Harvard Bioscience in Q1 2014 and held it in 22 quarters.
First Light Asset Management's Harvard Bioscience position peaked at $32.9M in Q3 2018.
71 funds tracked by Wall St. Rank held Harvard Bioscience as of Q3 2019.

Based on First Light Asset Management's 13F filing for Q3 2019, filed 14 Nov 2019.